Latest Tax Refunds News

Omega Oil & Gas has secured a $7.3 million refundable R&D tax offset for FY23, bolstering its financial position and supporting ongoing development of its promising Canyon Project in Queensland.

Imugene Limited has received a $5.87 million R&D tax refund, reinforcing its capacity to advance clinical trials in immuno-oncology. This funding milestone supports the development of its innovative cancer therapies, including CAR T cell treatments and oncolytic virotherapy.

Lindian Resources has secured a combined $1.65 million cash inflow from the exercise of unlisted options and a government R&D tax refund, strengthening its financial position for advancing the Kangankunde Rare Earths Project.

TruScreen Group Limited has launched a NZ$1.22 million Share Purchase Plan offering discounted shares to eligible investors, aiming to fuel growth in key international markets and public health initiatives.

Careteq Limited faces a significant repayment demand from the ATO over R&D tax claims but is mounting a formal objection backed by legal counsel.

Barton Gold Holdings has raised $3 million through a premium-priced placement to fast-track resource upgrade drilling at its Tunkillia Gold Project, boosting its cash reserves to $9 million with minimal dilution.

Health and Plant Protein Group Ltd (HPP) has received a US$3.38 million tax refund from the US IRS linked to its 2023 US subsidiary sale, slightly exceeding prior estimates. The company plans to return surplus assets to shareholders and pursue strategic growth opportunities under a leaner cost structure.

Anatara Lifesciences has obtained a $400,000 loan advance from a major shareholder group against its estimated R&D tax refund for the first half of FY2025, providing crucial funding to support ongoing clinical trials and product development without immediate capital raising.

Omega Oil and Gas has reported robust oil and gas flows from its Canyon-1H well in Queensland’s Bowen Basin, confirming commercial potential and securing $7 million in fresh capital alongside a strategic board appointment.

AXP Energy has completed a successful 60-day gas-to-power trial at its Pathfinder Field, delivering 1.5 MW of off-grid power and generating maiden natural gas revenue. The company is accelerating its expansion plans, backed by NASDAQ-listed BitFuFu, aiming to scale operations to 25 MW by year-end.

Evolution Energy Minerals initiates a strategic review and cost-cutting at its Chilalo graphite project while progressing a farm-out deal for its Chikundu Cu-Pb-Zn VHMS prospect with Oscillate plc.

Patrys Limited advances its PAT-DX3 therapy development for inflammatory diseases while navigating cash flow challenges and pursuing partnerships to sustain operations.